
Irving Family bequests $700 Million to Columbia and NewYork-Presbyterian for Cancer Research and Care
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving, have given $700 million to the two institutions to dramatically advance research and clinical programs for the treatment of cancer.
The $700 million bequest, which included $600 million in new funds in addition to previously announced pledges to the two organizations, brings the Irvings’ total donations to Columbia University and NewYork-Presbyterian to more than $900 million over the past three decades. Herbert Irving was a co-founder and former vice chairman of Sysco Corporation, the nation’s largest food distributor.
The Irvings’ historic gift will have a profound impact on research and clinical care at what is already one of the world’s preeminent academic medical centers at a time when new scientific tools and techniques are allowing researchers and clinicians to better understand how cancer begins and grows—and how to fight its spread. The new infusion of resources will help Columbia and NewYork-Presbyterian recruit the very best basic scientists, physician-scientists, and clinicians dedicated to producing a range of innovations in patient care, including improved efficacy of radiation therapy, new surgical approaches, and the development of a variety of new therapeutic options for patients. Facilities also will be expanded at the Herbert Irving Comprehensive Cancer Center, where more than 4,000 new cancer patients are treated each year. It is one of 47 comprehensive cancer centers in the U.S., one of the first to be designated by the National Cancer Institute for its capabilities in both cancer research and clinical care.
The Irvings’ extraordinary philanthropy will be felt across a wide range of scientific disciplines, including cancer genomics, immunology, computational biology, pathology, and biomedical engineering. (Columbia biochemist Joachim Frank shared the 2017 Nobel Prize in Chemistry for his pioneering work on the development of cryo-electron microscopy—a technique used to create high-resolution, three-dimensional images of life’s molecular machinery in atomic detail, allowing researchers to understand how changes in specific molecules cause disease, including cancer.) A key focus will be to further advance cancer research and clinical care in Columbia’s Precision Medicine Initiative which, in partnership with NewYork-Presbyterian, is exploring the genetic and genomic basis of cancer and other life-altering diseases.
The Irving name has long been a familiar part of Columbia and the Columbia campus of NewYork-Presbyterian. The Medical Center is home to the Herbert Irving Pavilion, the Irving Cancer Research Center, the Irving Institute for Clinical and Translational Research, the Irving Radiation Oncology Center, the Irving Bone Marrow Transplant Unit, and the Herbert Irving Comprehensive Cancer Center, as well as a long list of named professorships, faculty chairs, and clinical and research facilities. The Irvings’ generosity began with their 1987 endowment of the Irving Scholars program for early-career clinical investigators.
Tags:
Source: Herbert Irving Comprehensive Cancer Center
Credit:
